5.10% p.a. Early Redemption Worst of GOAL

Underlying: Biogen / Novo Nordisk / Takeda Pharmaceutical SSPA/EUSIPA Product Type: Reverse Convertibles (1220) Valor: 41051278 / ISIN: CH0410512781

Last update 19:35:00
  • Bid

    101.47 %
    Volume: --

  • Ask

    102.47 %
    Volume: --